Bank Hapoalim Bm Dexcom Inc Transaction History

Bank Hapoalim Bm

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$94.08 - $130.2 $46,851 - $64,839	-498 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$129.87 - $162.82 $13,636 - $17,096	-105 Reduced 17.41%	498 $267,000
Q3 2021 Oct 27, 2021	SELL	$106.71 - $143.18 $1,067 - $1,431	-10 Reduced 1.63%	603 $330,000
Q2 2021 Aug 05, 2021	SELL	$80.99 - $107.93 $13,039 - $17,376	-161 Reduced 20.8%	613 $262,000
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $10,506 - $12,424	-110 Reduced 12.44%	774 $319,000
Q2 2020 Aug 04, 2020	SELL	$62.68 - $105.34 $5,014 - $8,427	-80 Reduced 8.3%	884 $358,000
Q1 2020 May 06, 2020	SELL	$47.79 - $75.63 $29,438 - $46,588	-616 Reduced 38.99%	964 $260,000
Q3 2019 Nov 01, 2019	SELL	$35.53 - $43.8 $2,309 - $2,847	-65 Reduced 3.95%	1,580 $235,000
Q2 2019 Aug 06, 2019	BUY	$27.84 - $38.92 $45,796 - $64,023	1,645 New	1,645 $246,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

Stay updated on Bank Hapoalim Bm with notifications on news.